Lixte Biotechnology Holdings, Inc.
Cover
Document and Entity Information
Financial Statements
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements of Operations (Unaudited)
Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical)
Condensed Consolidated Statements of Stockholders' Equity (Unaudited)
Condensed Consolidated Statements of Cash Flows (Unaudited)
Notes to Financial Statements
Organization and Basis of Presentation
Business
Summary of Significant Accounting Policies
Stockholders' Equity
Related Party Transactions
Stock-Based Compensation
Commitments and Contingencies
Subsequent Events
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Summary of Significant Accounting Policies (Tables)
Stockholders' Equity (Tables)
Related Party Transactions (Tables)
Stock-Based Compensation (Tables)
Notes Details
Business (Details Narrative)
Summary of Significant Accounting Policies (Details Narrative)
Summary of Significant Accounting Policies - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)
Stockholders' Equity (Details Narrative)
Stockholders' Equity - Schedule of Warrants Outstanding (Details)
Related Party Transactions (Details Narrative)
Related Party Transactions - Summary of Related Party Costs (Details)
Stock-Based Compensation (Details Narrative)
Stock-Based Compensation - Summary of Stock-based Compensation Costs (Details)
Stock-Based Compensation - Summary of Stock Option Activity Including Options Form of Warrants (Details)
Stock-Based Compensation - Schedule of Exercise Prices of Common Stock Options Outstanding and Exercisable Including Options Form of Warrants (Details)
Commitments and Contingencies (Details Narrative)
Subsequent Events (Details Narrative)
All Reports
Filing Date:
08-10-2020
Form Type:
Form 10-Q
Description:
Quarterly Report